Skip to content
ppharmaranks
Menu

KANJINTI vs OGIVRI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 13, 2026·How we rate

Possible drug interaction. KANJINTI and OGIVRI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

72/100
66/100

Pharmacy pays

Type

RX
RX

Active ingredient

TRASTUZUMAB-ANNS
TRASTUZUMAB-DKST

Dosage forms

Injectable
Injectable, Kit

Drug class

Treats

Breast Neoplasms, Gastrointestinal Neoplasms
Breast Neoplasms, Gastrointestinal Neoplasms

Frequently asked questions

Which is better-rated, Kanjinti or Ogivri?

By our independent rating, Kanjinti scores higher — 3.6 vs 3.3 out of 5 for Ogivri. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Kanjinti and Ogivri?

Kanjinti contains Trastuzumab-Anns, while Ogivri contains Trastuzumab-Dkst — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.